Cat.#: BBM-3C-037
Description | Soluble Collagen TypeⅠ from Ace Therapeutics is purified fromBovine achilles tendon by the Birkedal-Hansen method. |
Source | Bovine achilles tendon |
Size | 1 mg/vial |
Form | White to off-white lyophilized |
Sterility | Passed sterility test for bacteria and fungi. |
Concentration | 10 mg/mL |
Storage | 2-8℃ for 8 years. |
Shipping | Dry ice |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-058 | Rat Tail Tendon Collagen Type I, 5mg/ml |
Rat Tail Tendon Collagen Type I, 5mg/ml is prepared by the method of Birkedal-Hansen through acetic acid extraction, sodium chloride precipitation, disodium hydrogen phosphate precipitation, and other steps.
This product can be used to coat cell culture vessels and culture some cells that are difficult to adhere to in ordinary cell culture vessels. It can also be used to prepare three-dimensional glue to simulate a real growth environment and allow cells to grow in a three-dimensional environment.
|
inquiry |
BBM-3C-021 | Canine Collagen Type I and III, 10 mg |
Canine Collagen Type I and III, 10 mg from Ace Therapeutics is purified from canine collagen.
Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-036 | Rat Tail Tendon Collagen Type I |
Rat Tail Tendon Collagen Type I from Ace Therapeutics is purified from rat tail by the Birkedal-Hansen method. This product can form a three-dimensional glue with a certain strength when the concentration is above 1mg/mL and the pH is around 7.
Note: This product can quickly gel at RT when the pH is neutral. Keep the temperature as low as possible during the operation.
|
inquiry |
BBM-3C-060 | Collagens Type I-P |
Collagens Type I-P is pepsin-solubilized Type-I collagen derived from pig tendon. The product has low viscosity, making it easy to handle and form gels.
|
inquiry |
BBM-3C-067 | Cultrex 3-D Culture Matrix Rat Collagen I |
Cultrex 3-D Culture Matrix Collagen I from Ace Therapeutics is purified from rat tail tendon with high concentrations. This product is capable of polymerizing to form hydrogels and is a purified matrix ECM protein specifically designed and developed for 3D culture.
|
inquiry |
BBM-3C-052 | Human Collagen Type IV |
Collagen Type IV is a common component of the basement membrane. Human Collagen Type IV from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and the product can be used to regulate cell growth, differentiation, and tissue formation.
|
inquiry |
BBM-3C-035 | Human Collagen Type V, 0.1mg |
Human Collagen Type V, 0.1mg from Ace Therapeutics is purified from human placenta.
Type V collagen, a fibrillar collagen, is critical for the fibrillation of types I and III collagen, contributing to optimal fibril formation and tissue quality.
|
inquiry |
BBM-3C-071 | Cultrex Rat Collagen I, Lower Viscosity |
Cultrex Rat Collagen I, Low Viscosity from Ace Therapeutics is a purified stromal extracellular matrix protein from rat tail tendons. This product is provided at a standard concentration that is lower in viscosity, making it easier to work with.
|
inquiry |
BBM-3C-042 | Collagen Type IV (Human Placenta) |
Collagen Type IV (Human Placenta) from Human Cell Culture from Ace Therapeutics is derived from human placenta and is highly purified native, type IV collagen.
|
inquiry |
BBM-3C-056 | Porcine Gelatine |
Porcine Gelatine from Ace Therapeutics is a purified gelatin matrix from porcine tissue. The product can enhance the adsorption of various normal cells and transfected cells.
|
inquiry |
We are committed to accelerating progress in stroke research and drug development.